Pharmaceutical Contract Packaging Market By Packaging Type (Primary Packaging, Secondary Packaging, Tertiary Packaging), By Product Type (Blister Packs, Bottles, Ampoules & Vials, Pre-Filled Syringes, Pouches), By Material Type (Plastic, Glass, Paper & Paperboard, Aluminum Foil), By Service Type (Bottling, Labeling, Serialization, Printing), By End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Clinical Research Organizations), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Pharmaceutical Contract Packaging Market was valued at USD 17.2 Billion in 2024-e and will surpass USD 24.8 Billion by 2030; growing at a CAGR of 6.3% during 2025-2030.

The pharmaceutical contract packaging market is a critical component of the healthcare supply chain, enabling pharmaceutical and biopharmaceutical companies to outsource packaging operations. This approach ensures cost optimization, regulatory compliance, and faster time-to-market for drugs. As the pharmaceutical industry grows, driven by increasing demand for biologics, personalized medicines, and stringent safety regulations, the contract packaging sector is experiencing robust expansion.

Primary Packaging Segment Is the Largest Owing to Its Direct Role in Drug Safety

Primary packaging, which includes components like blister packs, vials, and syringes, is the most critical as it comes in direct contact with drugs. This segment dominates due to its essential role in ensuring drug stability and safety. The rise in demand for biologics and vaccines, especially during the COVID-19 pandemic, has further driven the need for high-quality primary packaging.

Blister packs, a major subsegment within primary packaging, are particularly popular due to their ability to provide unit-dose protection and enhance patient compliance. Their dominance is attributed to widespread use in oral solid formulations and regulatory requirements for child-resistant and senior-friendly designs.

Pre-Filled Syringes Lead Product Type Segment, Fueled by Biologic Drugs

Among product types, pre-filled syringes are the fastest-growing subsegment, driven by the rise of biologics and injectable drugs. These syringes offer convenience, reduced risk of contamination, and precise dosing, making them a preferred choice for patients and healthcare providers.

The adoption of pre-filled syringes is particularly strong in therapeutic areas like diabetes and oncology, where self-administration of injectable drugs is becoming increasingly common. Manufacturers are also innovating with dual-chamber and safety-engineered syringes to meet evolving market needs.

Plastic Materials Dominate Packaging Solutions Due to Versatility

Plastic materials hold the largest share in the pharmaceutical contract packaging market due to their versatility, lightweight nature, and cost-effectiveness. Plastics such as polyethylene and polypropylene are widely used for packaging bottles, blister packs, and pouches.

The demand for plastic is further fueled by advancements in barrier properties, which enhance drug stability and shelf life. However, sustainability concerns are pushing companies to develop recyclable and biodegradable plastic solutions, aligning with global environmental goals.

Serialization Services Are Growing Rapidly Due to Regulatory Compliance Needs

Serialization is the fastest-growing segment within services, driven by stringent regulations to combat counterfeit drugs. Serialization involves the assignment of unique identifiers to individual packages, ensuring traceability and improving supply chain transparency.

The adoption of serialization services has surged in regions such as North America and Europe, where regulatory mandates like the U.S. Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (FMD) require compliance. This trend is expected to expand globally as more countries implement similar regulations.

Biopharmaceutical Companies Drive End-User Segment Growth

Biopharmaceutical companies represent the largest end-user segment due to the high volume of biologics and advanced therapies requiring specialized packaging. These companies often outsource packaging to focus on core competencies, such as drug development and innovation.

The complexity of biologics, which require temperature-sensitive and contamination-free packaging, has led to an increased reliance on contract packaging providers with expertise in handling such products. This trend is expected to continue as the biopharmaceutical pipeline grows.

Asia-Pacific Emerges as the Fastest-Growing Region Due to Expanding Manufacturing Base

Asia-Pacific is the fastest-growing region in the pharmaceutical contract packaging market, driven by the region's expanding pharmaceutical manufacturing base and cost advantages. Countries such as India and China are leading contributors, supported by government initiatives and investments in healthcare infrastructure.

The region also benefits from a growing population, increasing healthcare awareness, and rising demand for generic drugs. Additionally, the presence of a skilled workforce and low operational costs make Asia-Pacific a hub for contract packaging services.

Competitive Landscape and Leading Companies

The pharmaceutical contract packaging market is highly competitive, with key players focusing on innovation, capacity expansion, and sustainability to gain a competitive edge. Leading companies such as Catalent, Inc., Lonza Group AG, and Thermo Fisher Scientific Inc. dominate the market with extensive service portfolios and global reach.

Mergers and acquisitions are common, enabling companies to expand their capabilities and geographic presence. For example, Thermo Fisher's acquisition of PPD highlights the trend of consolidation to enhance service offerings. The competitive landscape is also influenced by the push for eco-friendly solutions, with companies investing in sustainable packaging materials and processes to meet evolving customer and regulatory demands.

Recent Developments:

• Catalent announced the opening of a new biologics packaging facility in Bloomington, Indiana, to enhance its capacity for advanced therapies.
• Thermo Fisher Scientific completed the acquisition of PPD to strengthen its clinical research and packaging services.
• Gerresheimer AG launched a new line of eco-friendly glass and plastic packaging targeting sustainability-conscious customers.
• PCI Pharma expanded its capabilities by acquiring a lyophilization and sterile fill-finish facility in Bedford, New Hampshire.
• Schott AG signed a deal with BioNTech to supply high-quality vials for COVID-19 vaccine distribution.

List of Leading Companies:

• Catalent, Inc.
• Lonza Group AG
• Thermo Fisher Scientific Inc.
• West Pharmaceutical Services, Inc.
• Gerresheimer AG
• Vetter Pharma International GmbH
• PCI Pharma Services
• Sharp Packaging Services
• Amcor Plc
• Schott AG
• CordenPharma International
• Almac Group
• UDG Healthcare Plc
• Bilcare Limited
• Aphena Pharma Solutions

Report Scope: